NCT06272981View on ClinicalTrials.gov

A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS

NAActive, not recruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

October 29, 2025

Study Completion Date

October 29, 2025

Conditions
Atrial Fibrillation
Interventions
DEVICE

Pulsed Field (PF) /Radiofrequency (RF) Catheter ablation

THERMOCOOL STSF catheter will be used in conjunction with TRUPULSE Generator to give PF ablation or RF ablation.

Trial Locations (7)

2050

Royal Prince Alfred Hospital, Camperdown

2145

Westmead Hospital, Westmead

2605

Canberra Heart Rhythm, Garran

L3Y 2P9

Southlake Regional Health Centre, Newmarket

K1Y 4W7

University of Ottawa Heart Institute, Ottawa

H1T 1C8

Montreal Heart Institute, Montreal

H3G 1A4

McGill University Health Centre, Montreal

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT06272981 - A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS | Biotech Hunter | Biotech Hunter